Ledger.Open graph →
SEC Form D · filed August 11, 2016

Biosceptre International Ltd

Offering
—
Sold
$672K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BABRAHAM, CAMBRIDGE, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Jonathan J. Collins · Babraham, Cambridge, United KingdomDirectorRonald S. Watts · Babraham, Cambridge, United KingdomDirectorPaul J. Axon · Babraham, Cambridge, United KingdomDirectorAndrew J. Walton-Green · Babraham, Cambridge, United KingdomDirectorMichael J. Lovett · Babraham, Cambridge, United KingdomDirectorGregory J. Winter · Babraham, Cambridge, United KingdomDirectorPeter J. Newton · Babraham, Cambridge, United KingdomDirectorShaun J. Mcnulty · Babraham, Cambridge, United KingdomExecPeter G. Currie · Babraham, Cambridge, United KingdomExec · DirectorGary Pestano, Ph.D · Boulder, COExecWilliam C. Crosby · Memphis, TNDirectorDarcy C. Curran · Memphis, TNExec · DirectorBrian Kaas · Madison, WIDirectorPaul Beresford, Ph.D · Boulder, CODirectorDavid R. Zook · BUFFALO, WYDirectorHeinrich Roder, D.Phil · Boulder, CODirectorJim Purvis · Boulder, CODirectorCarla Coleman · Windermere, FLDirectorMRR Advisors Management, LLC · Southlake, TXDirectorEdward D. Dobbs · Memphis, TNDirectorBobbi Coffin · Boulder, COExec · DirectorLinda Traylor, Ph.D · Boulder, CODirectorAlan Grayson · Windermere, FLDirectorMatthew Redding · Southlake, TXExecRobert D. Peiser · Memphis, TNDirectorBruce S. Feuchter · Newport Beach, CADirectorElizabeth Granville-Smith · BOSTON, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗